WKWilhelm Krek

Wilhelm Krek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wilhelm Krek has a total of 112 co-authors. Here are the top co-authors by number of shared publications:

  • Christiane Wirbelauer

    Institute for Cell Biology, ETH Zurich, 8093 Zurich, Switzerland

    4 shared publications
  • Carsten Danzer

    Institute of Cell Biology

    3 shared publications
  • Daniel Hess

    Institute of Cell Biology, ETH-Hönggerberg, 8093 Zurich, Switzerland,1 Friedrich Miescher Institute, Maulbeerstrasse 66, 4058 Basel, Switzerland,2 Department of Biology, University of Konstanz, D-78457 Konstanz, Germany,3 Zurich PhD Program in Molecular Life Sciences, Zurich, Switzerland4

    3 shared publications
  • Andrea Minola

    Institute of Cell Biology, ETH Zurich, Zurich, Switzerland,1 Institute of Surgical Pathology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland,2 Génétique Oncologique EPHE, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, and CNRS FRE-2939, Institute de Cancerologie Gustave Roussy, Villejuif, France,3 Surgical Neurology Branch, NINDS, National Institutes of Health, Bethesda, Maryland4

    2 shared publications
  • Claudio R. Thoma

    Institute of Cell Biology, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland

    2 shared publications
  • Dimitrios Anastasiou

    The Francis Crick Institute

    2 shared publications

Latest Publications

  • Open Access

    Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system

    by Jaya Krishnan, Carsten Danzer, Tatiana Simka, Josef Ukropec, Katharina Manuela Walter, Susann Kumpf, Peter Mirtschink, Barbara Ukropcova, Daniela Gasperikova, Thierry Pedrazzini, et al.

    Dietary obesity is a major factor in the development of type 2 diabetes and is associated with intra-adipose tissue hypoxia and activation of hypoxia-inducible factor 1α (HIF1α). Here we report that, in mice, Hif1α activation in visceral white adipocytes is critical to maintain dietary obesity and associated pathologies, including glucose intolerance, insulin resistance, and cardiomyopathy. This function of Hif1α is linked to its capacity to suppress β-oxidation, in part, through transcriptional repression of sirtuin 2 (Sirt2) NAD+-dependent deacetylase. Reduced Sirt2 function directly translates into diminished deacetylation of PPARγ coactivator 1α (Pgc1α) and expression of β-oxidation and mitochondrial genes. Importantly, visceral adipose tissue from human obese subjects is characterized by high levels of HIF1α and low levels of SIRT2. Thus, by negatively regulating the Sirt2–Pgc1α regulatory axis, Hif1α negates adipocyte-intrinsic pathways of fatty acid catabolism, thereby creating a metabolic state supporting the development of obesity.


  • Comprehensive Description of the N-Glycoproteome of Mouse Pancreatic β-Cells and Human Islets

    by Carsten Danzer, Katrin Eckhardt, Alexander Schmidt, Niklaus Fankhauser, Sebastien Ribrioux, Bernd Wollscheid, Lukas Müller, Ralph Schiess, Richard Züllig, Roger Lehmann, et al.


  • Open Access

    Identification of a Gene Expression Signature Common to Distinct Cancer Pathways

    by Niklaus Fankhauser, Igor Cima, Peter Wild, Wilhelm Krek

    Mutations in cancer-causing genes induce changes in gene expression programs critical for malignant cell transformation. Publicly available gene expression profiles produced by modulating the expression of distinct cancer genes may therefore represent a rich resource for the identification of gene signatures common to seemingly unrelated cancer genes. We combined automatic retrieval with manual validation to obtain a data set of high-quality gene microarray profiles. This data set was used to create logical models of the signaling events underlying the observed expression changes produced by various cancer genes and allowed to uncover unknown and verifiable interactions. Data clustering revealed novel sets of gene expression profiles commonly regulated by distinct cancer genes. Our method allows retrieval of significant new information and testable hypotheses from a pool of deposited cancer gene expression experiments that are otherwise not apparent or appear insignificant from single measurements. The complete results are available through a web-application at http://biodata.ethz.ch/cgi-bin/geologic .


  • Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T

    by Qiong Ye, Carsten Friedrich Danzer, Alexander Fuchs, Wilhelm Krek, Thomas Mueggler, Christof Baltes, Markus Rudin

    Insulin resistance is a central feature of type II diabetes and is associated with alterations in skeletal muscle lipid metabolism, which manifest themselves, in part, in increased intramyocellular lipid (IMCL) accumulation. The objective of this study was to assess noninvasively the levels of IMCL longitudinally in the tibialis anterior muscle of Lepob/Lepob (ob/ob) mice, a genetic model of obesity and mild diabetes, and Lepob/+ (ob/ + ) heterozygous control animals, using 1H MRS at 9.4 T. The use of a cryogenic surface coil transceiver leads to significant increases in sensitivity. Method implementation included the assessment of the reproducibility and spatial heterogeneity of the IMCL signal and the determination of T2 relaxation times, as IMCL levels were expressed relative to the total creatine signal, and therefore the signal ratios had to be corrected for differences in T2 relaxation. IMCL levels were found to be significantly higher in ob/ob mice relative to ob/+ heterozygous control mice that do not develop disease. An increase in IMCL levels was observed for ob/ob mice until weeks 16/17; after this time point, IMCL levels decreased again, reaching final levels that were slightly higher than the initial values. These noninvasively detected alterations in skeletal muscle lipid metabolism in ob/ob mice were accompanied by a transient increase in plasma insulin concentrations. This study indicates that IMCL may be reliably assessed in mouse tibialis anterior muscle using a cryogenic surface coil, implying that 1H MRS at 9.4 T represents a useful technology for the noninvasive measurement of changes in lipid metabolism in the skeletal muscle that accompany obesity. Copyright © 2011 John Wiley & Sons, Ltd.


  • Open Access

    Mechanisms of aneuploidy and its suppression by tumour suppressor proteins

    by C Thoma, A Toso, P Meraldi, W Krek

    Aneuploidy, as a result of numerical changes in chromosome number, was observed in tumours almost a century ago. The molecular mechanisms underlying this phenomenon and their impact on tumour development are still poorly understood. A series of recent observations provide direct linkages between the normal function of tumour suppressor proteins and the suppression of aneuploidy. The prospects that these findings offer for understanding the role of aneuploidy in cancer are discussed in this review.


  • Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

    by Igor Cima, Ralph Schiess, Peter Wild, Martin Kaelin, Peter Schüffler, Vinzenz Lange, Paola Picotti, Reto Ossola, Arnoud Templeton, Olga Schubert, et al.

    A key barrier to the realization of personalized medicine for cancer is the identification of biomarkers. Here we describe a two-stage strategy for the discovery of serum biomarker signatures corresponding to specific cancer-causing mutations and its application to prostate cancer (PCa) in the context of the commonly occurring phosphatase and tensin homolog ( PTEN ) tumor-suppressor gene inactivation. In the first stage of our approach, we identified 775 N -linked glycoproteins from sera and prostate tissue of wild-type and Pten -null mice. Using label-free quantitative proteomics, we showed that Pten inactivation leads to measurable perturbations in the murine prostate and serum glycoproteome. Following bioinformatic prioritization, in a second stage we applied targeted proteomics to detect and quantify 39 human ortholog candidate biomarkers in the sera of PCa patients and control individuals. The resulting proteomic profiles were analyzed by machine learning to build predictive regression models for tissue PTEN status and diagnosis and grading of PCa. Our approach suggests a general path to rational cancer biomarker discovery and initial validation guided by cancer genetics and based on the integration of experimental mouse models, proteomics-based technologies, and computational modeling.


  • Open Access

    Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability

    by Claudio R. Thoma, Alexandre Matov, Katrin L. Gutbrodt, Christian R. Hoerner, Zlatko Smole, Wilhelm Krek, Gaudenz Danuser

    Von Hippel-Lindau (VHL) tumor suppressor gene mutations predispose carriers to kidney cancer. The protein pVHL has been shown to interact with microtubules (MTs), which is critical to cilia maintenance and mitotic spindle orientation. However, the function for pVHL in the regulation of MT dynamics is unknown. We tracked MT growth via the plus end marker EB3 (end-binding protein 3)-GFP and inferred additional parameters of MT dynamics indirectly by spatiotemporal grouping of growth tracks from live cell imaging. Our data establish pVHL as a near-optimal MT-stabilizing protein: it attenuates tubulin turnover, both during MT growth and shrinkage, inhibits catastrophe, and enhances rescue frequencies. These functions are mediated, in part, by inhibition of tubulin guanosine triphosphatase activity in vitro and at MT plus ends and along the MT lattice in vivo. Mutants connected to the VHL cancer syndrome are differentially compromised in these activities. Thus, single cell–level analysis of pVHL MT regulatory function allows new predictions for genotype to phenotype associations that deviate from the coarser clinically defined mutant classifications.


  • Open Access

    PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis

    by Nabil Djouder, Roland D Tuerk, Marianne Suter, Paolo Salvioni, Ramon F Thali, Roland Scholz, Kari Vaahtomeri, Yolanda Auchli, Helene Rechsteiner, René A Brunisholz, et al.

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.